Validation of the Greek Postoperative Quality of Recovery Score 15 ((QoR-15Gr))
Cultural Adaptation and Validation of the Greek Version of the Postoperative Quality of Recovery Score 15 (QoR-15Gr)
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: DESPOINA LIOTIRI, ANAESTHESIOLOGIST
- Phone Number: 00306947941422
- Email: deppieliotiri@gmail.com
Study Contact Backup
- Name: NIKOLAOS BEIS, SURGICAL TRAINEE
- Phone Number: 00306984033002
- Email: mpeis_nik@yahoo.gr
Study Locations
-
-
Thessaly
-
Larissa, Thessaly, Greece, 41005
- IASO Thessalias General Hospital
-
Contact:
- DESPOINA LIOTIRI, ANAESTHESIOLOGIST
- Phone Number: 00306947941422
- Email: deppieliotiri@gmail.com
-
Principal Investigator:
- DESPOINA LIOTIRI, ANAESTHESIOLOGIST
-
Principal Investigator:
- NIKOLAOS BEIS, SURGICAL TRAINEE
-
Sub-Investigator:
- ATHINA SAMARA, GYNAECOLOGY TRAINEE
-
Sub-Investigator:
- ALEXANDROS DIAMANTIS, SURGEON
-
Sub-Investigator:
- DIMITRIOS ZACHAROULIS, PROFESSOR OF SURGERY
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age>18 years old
- Scheduled elective general surgery under general anesthesia
Exclusion Criteria:
- Emergency surgery
- Poor Greek comprehension
- Inability to give consent
- A psychiatric or neurological condition that precludes cooperation
- Known history of alcohol or drug dependence
- Life-threatening postoperative complications
- Postoperative admission to ITU
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Translation and cultural adaptation of the Greek version of the postoperative quality of recovery score 15 (QoR-15Gr)
Time Frame: From enrollment until 20 first patient have been enrolled
|
The QoR-15 consists of 15 questions and the patients are asked to rate various aspects of their postoperative recovery from 0 to 10. Minimum score is 0 and corresponds to the worst score. Maximum score is 150 and corresponds to optimal recovery. Translation into Greek and pilot test will be performed. |
From enrollment until 20 first patient have been enrolled
|
|
Psychometric properties of postoperative quality of recovery 15 (QoR-15Gr) will be assessed by evaluating validity (convergent, construct, and discriminant), reliability (internal consistency and repeatability), and responsiveness.
Time Frame: From enrollment until 150 patients have been enrolled
|
From enrollment until 150 patients have been enrolled
|
|
|
Acceptability and feasibility of the postoperative quality of recovery 15 (QoR-15Gr) will be assessed by measuring patient recruitment rate as well as successful recruitment rate.
Time Frame: From enrollment until 150 patients have been enrolled
|
From enrollment until 150 patients have been enrolled
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: DESPOINA LIOTIRI, ANAESTHESIOLOGIST, IASO Thessalias General Hospital
- Study Chair: DIMITRIOS ZACHAROULIS, PROFESSOR OF SURGERY, University of Thessaly
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Estimated)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 785
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.